attenuated Chlamydophila felis (905 strain) EU-MED Not yet graded
EU medicine: Authorised, Lapsed
Class as recordedQI06AH
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002036
Compound index — A
1,493 substances begin with A. 5 of them carry an Etalyn grade; the remainder are marked not yet graded, which is a statement about Etalyn’s coverage and not about the substance. This page shows 93 of them, attenuated Chlamydophila… – Azúcares de frutas de….
US-DRUGListed as a marketed drug substance in the United StatesEU-MEDActive substance in a centrally authorised EU medicineEU-HERBSubject of an EU herbal monographUS-CSAScheduled under the US Controlled Substances ActCA-NHPLicensed supplement ingredient in CanadaEU-CLAIMAppears in the EU nutrition and health claims registerEU-NOVELAppears in the EU novel food catalogueETALYNEtalyn has graded a claim about this substance
attenuated feline panleucopenia virus (PLI IV) EU-MED Not yet graded
EU medicine: Authorised
Market presence4 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002037
attenuated feline rhinotracheitis herpesvirus (FHV F2 strain) EU-MED Not yet graded
EU medicine: Authorised, Lapsed
Class as recordedQI06AH
Market presence5 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002038
attenuated live rabies vaccine virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002039
Aucklandia lappa CA-NHP Not yet graded
CA licensed ingredient
Market presence29 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002040
Aumolertinib mesilate EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01EB
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002041
Auranofin US-DRUG Not yet graded
US: bulk ingredient
Earliest US approval1985
Market presence3 US product listings · 1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002042
Aureobasidium Pullulans Var. Pullutans US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Antigens
Market presence36 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002043
Auricularia auricula-judae CA-NHP Not yet graded
CA licensed ingredient
Market presence45 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002044
Auricularia polytricha EU-NOVEL Not yet graded
Not novel in food
also: Hirneola polytricha
Parts in scopeFruiting body
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002045
Aurum chloratum CA-NHP Not yet graded
CA licensed ingredient
Market presence11 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002046
Aurum iodatum CA-NHP Not yet graded
CA licensed ingredient
Market presence10 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002047
Aurum metallicum CA-NHP Not yet graded
CA licensed ingredient
Market presence103 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002048
Aurum muriaticum CA-NHP Not yet graded
CA licensed ingredient
Market presence36 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002049
Aurum muriaticum natronatum CA-NHP Not yet graded
CA licensed ingredient
Market presence8 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002050
Aurum sulphuratum CA-NHP Not yet graded
CA licensed ingredient
Market presence5 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002051
autologous cartilage-derived articular chondrocytes EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedM09AX02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002052
autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedB06A
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002053
autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human adenosine deaminase (ADA) cDNA sequence from human haematopoietic stem/progenitor (CD34+) cells EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL03
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002054
Autologous Cultured Chondrocytes EU-MEDUS-DRUG Not yet graded
autologous glioma tumor cell lysates (inactivated) EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL01XX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002056
autologous glioma tumor cells (inactivated) EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedL01XX
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002057
autologous human chondrocytes in vitro expanded EU-MED Not yet graded
EU medicine: Application withdrawn
Class as recordedM09AX02
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002058
autologous melanoma-derived tumor infiltrating lymphocytes EU-MED Not yet graded
EU medicine: Opinion
Class as recordedL01XL
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002059
autologous peripheral blood T cells CD4 and CD8 selected and CD3 and CD28 activated transduced with retroviral vector expressing anti-CD19 CD28/CD3-zeta chimeric antigen receptor and cultured (brexucabtagene autoleucel) EU-MED Not yet graded
EU medicine: Authorised
Class as recordedL01X
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002060
autologous peripheral-blood mononuclear cells including a minimum of 50 million autologous CD54+ cells activated with prostatic acid phosphatase granulocyte-macrophage colony-stimulating factor EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedL03AX17
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002061
Auxenochlorella protothecoides CA-NHPEU-NOVEL Not yet graded
Not novel in foodCA licensed ingredient
also: R.W.Krauss 1965; Graesiella emersonii; Chlorella emersonii Shihira &; Chlorella protothecoides Krüger 1894, Palmellococcus protothecoides (Krüger) Chodat 1909, Auxenochlorella protothecoides var. galactophila Unknown authority 0, Chlorella protothecoides var. galactophila Shihira &
Market presence2 Canadian licensed products
Parts in scopeWhole
Etalyn identifierETA-C-002062
Avacincaptad Pegol EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawnUS: bulk ingredient
Class as recordedComplement Inhibitor [EPC]; Complement Inhibitors [MoA]; S01XA32
Earliest US approval2023
Market presence2 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002064
Avacopan EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: bulk ingredient
Class as recordedComplement 5a Receptor Antagonist [EPC]; Complement 5a Receptor Antagonists [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; L04
Earliest US approval2021
Market presence9 US product listings · 1 FDA applications · 2 EU medicines
Etalyn identifierETA-C-002065
Avalglucosidase Alfa EU-MEDUS-DRUG Not yet graded
Avalglucosidase Alfa-Ngpt US-DRUG Not yet graded
Earliest US approval2021
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002067
Avanafil EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedG04BE10; Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
Earliest US approval2012
Market presence10 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002068
Avapritinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedBile Salt Export Pump Inhibitors [MoA]; Breast Cancer Resistance Protein Inhibitors [MoA]; Cytochrome P450 2C9 Inhibitors [MoA]; Kinase Inhibitor [EPC]
Earliest US approval2020
Market presence11 US product listings · 1 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002069
Avelumab EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAntibodies; L01FF04; Monoclonal [CS]; Programmed Death Ligand-1 Antagonists [MoA]
Earliest US approval2017
Market presence1 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002071
Avena fatua CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002072
Avena sativa CA-NHP Not yet graded
CA licensed ingredient
Market presence1,029 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002073
Avena Sativa (oat) Bran US-DRUG Not yet graded
US: drug for further processing
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002074
Avena Sativa Flowering TOP US-DRUG Not yet graded
US: drug for further processing
Class as recordedAcidifying Activity [MoA]; Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]
Market presence188 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002075
Avena sativa L. EU-NOVEL Not yet graded
Novel, not yet authorised
Parts in scopeOat shoots (oat grass); Oat seeds/grains/kernels and fiber from the aerial parts including hull; Oats fermented with Lactiplantibacillus plantarum in liquid or dry form
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002076
Avena Sativa Leaf US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedIncreased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]
Market presence4 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002077
Avena Sativa Pollen US-DRUG Not yet graded
US: bla
Class as recordedAdrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]
Market presence32 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002078
Avena sativa semen CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002079
Avena Sativa TOP US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002080
Avena Sativa Whole US-DRUG Not yet graded
US: bla
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002081
Avenae fructus EU-HERB Not yet graded
Herbal monograph: C: ongoing call for scientific data
also: Oat Herb; Oat Fruit; Avenae herba; Avena sativaL.
Class as recordedherbal: Skin disorders and minor wounds; herbal: Sleep disorders and temporary insomnia;Mental stress and moo
Recorded fromEU-HERB — 1 of 7 registers
Etalyn identifierETA-C-002082
Avens CA-NHP Not yet graded
CA licensed ingredient
Market presence2 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002083
Aviaire CA-NHP Not yet graded
CA licensed ingredient
Market presence3 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002084
avian infectious bronchitis EU-MED Not yet graded
EU medicine: Authorised
Market presence3 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002085
avian infectious bursal disease EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002086
Avian influenza virus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002087
avian metapneumovirus EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002088
avian reovirus EU-MED Not yet graded
EU medicine: Authorised
Market presence2 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002089
avian reovirus and egg drop syndrome virus vaccine (inactivated) EU-MED Not yet graded
EU medicine: Authorised
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002090
Avibactam EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedCephalosporin Antibacterial [EPC]; Cephalosporins [CS]; J01DD52; J01DF51
Earliest US approval2015
Market presence5 US product listings · 2 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002091
Avicularia Avicularia US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Copper [CS]; Copper-containing Intrauterine Device [EPC]
Market presence10 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002092
Aviptadil US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002093
Aviscumine US-DRUG Not yet graded
US: unapproved homeopathic
Class as recordedAllergens [CS]; Ammonium Ion Binding Activity [MoA]; Bee Venoms [CS]; Calculi Dissolution Agent [EPC]
Market presence8 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002094
Avobenzone US-DRUG Not yet graded
US: bulk ingredient
Class as recordedAcidifying Activity [MoA]; Adenosine Receptor Agonist [EPC]; Adenosine Receptor Agonists [MoA]; Allergens [CS]
Earliest US approval1992
Market presence2,729 US product listings · 5 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002095
Avocado Oil US-DRUG Not yet graded
US: unapproved drug other
Market presence2 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002096
Avocado unsaponifiables CA-NHP Not yet graded
CA licensed ingredient
Market presence1 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002097
Avocado-soy extract EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “Natural flexibility for the joints. Accelerates the formation of new cartilage by increasing the formation of cartilage growth factors. Facilitates exercise. Activates the building of joint cartilage. Natural flexibility remains. Accelerates the formation of collagen in joint membrane cells (synoviocytes).” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002098
Avocado-soybean unsaponifiables CA-NHP Not yet graded
CA licensed ingredient
Market presence61 Canadian licensed products
Recorded fromCA-NHP — 1 of 7 registers
Etalyn identifierETA-C-002099
Avutometinib Potassium US-DRUG Not yet graded
Earliest US approval2025
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002100
Axatilimab US-DRUG Not yet graded
US: bla
Class as recordedColony Stimulating Factor Receptor Type 1 (CSF-1R) Inhibitors [MoA]; Colony Stimulating Factor-1 Receptor Blocker [EPC]
Market presence6 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002101
axatilimab-csfr US-DRUG Not yet graded
Earliest US approval2024
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002102
Axicabtagene Ciloleucel EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bla
Class as recordedAutologous; CD19 Receptor Interactions [MoA]; CD19-directed Chimeric Antigen Receptor [EPC]; CD19-specific Chimeric Antigen Receptor [CS]
Market presence1 US product listings · 1 EU medicines
Etalyn identifierETA-C-002103
Axitinib EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: bulk ingredient
Class as recordedKinase Inhibitor [EPC]; L01EK01; Receptor Tyrosine Kinase Inhibitors [MoA]
Earliest US approval2012
Market presence7 US product listings · 4 FDA applications · 2 EU medicines
Etalyn identifierETA-C-002104
Azacitidine EU-MEDUS-DRUG Not yet graded
EU medicine: Application withdrawn, AuthorisedUS: anda
Class as recordedL01BC07; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]
Earliest US approval2004
Market presence47 US product listings · 19 FDA applications · 8 EU medicines
Etalyn identifierETA-C-002105
Azadirachta indica CA-NHPEU-NOVEL Not yet graded
Not novel in supplementsCA licensed ingredient
also: Neem; Crack Jack; Indian Lilac; Antelea azadirachta (L.) ADELBERT; Antelea javanica GAERTN., Melia azadirachta L., Melia indica (A.JUSS.) BRANDIS)
Market presence161 Canadian licensed products
Parts in scopeFruit; Leaves; Oil from the fruits
Etalyn identifierETA-C-002106
Azadirachta Indica Bark US-DRUG Not yet graded
US: drug for further processing
Class as recordedAllergens [CS]; Bee Venoms [CS]; Blood Coagulation Factor [EPC]; Calcium [CS]
Market presence19 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002107
Azadirachta Indica Flower US-DRUG Not yet graded
US: unapproved homeopathic
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002108
Azadirachta Indica Seed Oil US-DRUG Not yet graded
US: otc monograph drug
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002109
Azaerythromycin A US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002110
azagly-nafarelin EU-MED Not yet graded
EU medicine: Withdrawn
Class as recordedQH01CA
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002111
Azaperone US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002112
Azatadine Maleate US-DRUG Not yet graded
Earliest US approval1977
Market presence2 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002113
Azathioprine EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedL04AX01; Nucleic Acid Synthesis Inhibitors [MoA]; Nucleosides [CS]; Purine Antimetabolite [EPC]
Earliest US approval1968
Market presence45 US product listings · 9 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002114
Azelaic Acid US-DRUG Not yet graded
US: anda
Class as recordedDecreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]
Earliest US approval1995
Market presence29 US product listings · 9 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002115
Azelastine Hydrochloride US-DRUG Not yet graded
US: anda
Class as recordedCorticosteroid Hormone Receptor Agonists [MoA]; Corticosteroid [EPC]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]
Earliest US approval1996
Market presence50 US product listings · 35 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002116
Azelastine Hydrochrloride US-DRUG Not yet graded
Earliest US approval2009
Market presence1 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002117
Azilsartan US-DRUG Not yet graded
US: bulk ingredient
Market presence1 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002118
Azilsartan Kamedoxomil US-DRUG Not yet graded
US: anda
Class as recordedAngiotensin 2 Receptor Blocker [EPC]; Angiotensin 2 Type 1 Receptor Antagonists [MoA]; Decreased Blood Pressure [PE]; Increased Diuresis [PE]
Earliest US approval2011
Market presence15 US product listings · 4 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002119
Azilsartan Medoxomil EU-MEDUS-DRUG Not yet graded
Azithromycin US-DRUG Not yet graded
US: anda
Class as recordedMacrolide Antimicrobial [EPC]; Macrolides [CS]
Earliest US approval1991
Market presence230 US product listings · 75 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002121
Azithromycin, Unspecified Form US-DRUG Not yet graded
US: bulk ingredient
Market presence3 US product listings
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002122
Azlocillin Sodium US-DRUG Not yet graded
Market presence3 FDA applications
Recorded fromUS-DRUG — 1 of 7 registers
Etalyn identifierETA-C-002123
Aztreonam EU-MEDUS-DRUG Not yet graded
EU medicine: AuthorisedUS: anda
Class as recordedJ01DF51; Monobactam Antibacterial [EPC]; Monobactams [CS]; beta Lactamase Inhibitor [EPC]
Earliest US approval1986
Market presence21 US product listings · 8 FDA applications · 1 EU medicines
Etalyn identifierETA-C-002124
aztreonam lysine EU-MED Not yet graded
EU medicine: Authorised
Class as recordedJ01DF01
Market presence1 EU medicines
Recorded fromEU-MED — 1 of 7 registers
Etalyn identifierETA-C-002125
Azuki bean (Phaseolus angularis) product EU-NOVEL Not yet graded
Not novel in food
also: Azukia angularis (Willd.) Ohwi; Vigna angularis var. angularis; Phaseolus angularis (Willd.) W.Wight
Parts in scopeflour protein hydrolysate and enriched protein hydrolysate
Recorded fromEU-NOVEL — 1 of 7 registers
Etalyn identifierETA-C-002127
Azurite CA-NHPUS-DRUG Not yet graded
CA licensed ingredientUS: unapproved homeopathic
Class as recordedAllergens [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]
Market presence1 US product listings · 2 Canadian licensed products
Etalyn identifierETA-C-002128
Azúcares de frutas de bajo índice glicémico EU-CLAIM Not yet graded
EU claims 0 authorised / 1 refused
Claims examined by the EU — wording reproduced, not Etalyn’s.
| Claim as submitted | Ruling | Basis | Opinion |
|---|---|---|---|
| “ayudan a mantener constantes los niveles de glucosa en sangre. Clarification provided it helps to maintain steady blood glucose levels.” | Non-authorised | Art.13(1) | EFSA opinion |
Recorded fromEU-CLAIM — 1 of 7 registers
Etalyn identifierETA-C-002126